Evolution of clinically isolated syndrome to pediatric-onset multiple sclerosis and a review of the literature
Background/aim: Clinically isolated syndrome (CIS) may be the first presentation of pediatric
onset multiple sclerosis (POMS). We retrospectively evaluated the clinical and laboratory …
onset multiple sclerosis (POMS). We retrospectively evaluated the clinical and laboratory …
Retrospective analysis of children with myelin oligodendrocyte glycoprotein antibody-related disorders
B Konuskan, M Yildirim, R Gocmen, TD Okur… - Multiple sclerosis and …, 2018 - Elsevier
Background Knowledge has been expanding on myelin oligodendrocyte glycoprotein
(MOG) antibody-associated central nervous system disorders. We delineate the clinical and …
(MOG) antibody-associated central nervous system disorders. We delineate the clinical and …
Narrative review based on fingolimod therapy in pediatric MS
B Piri Cinar, B Konuskan, B Anlar… - SAGE Open …, 2023 - journals.sagepub.com
The course of pediatric-onset multiple sclerosis and adult multiple sclerosis shows some
clinical differences. The rate of having a second attack after the first clinical event is 80% in …
clinical differences. The rate of having a second attack after the first clinical event is 80% in …
[HTML][HTML] Trends in the environmental risks associated with earlier onset in multiple sclerosis
Background Several environmental and lifestyle factors relating to sunlight/vitamin D, body
mass index (BMI), and smoking are associated with the risk of developing multiple sclerosis …
mass index (BMI), and smoking are associated with the risk of developing multiple sclerosis …
What an adult multiple sclerosis registry can tell us about pediatric onset multiple sclerosis?
Abstract Background Multiple Sclerosis (MS) is an immune-mediated, chronic disease of the
central nervous system that affects mainly adults. However, it is increasingly recognized that …
central nervous system that affects mainly adults. However, it is increasingly recognized that …
Pediatric multiple sclerosis and its familial recurrence: A population based study (1999–2017)
S Eskandarieh, MA Sahraiain, N Molazadeh… - Multiple sclerosis and …, 2019 - Elsevier
Abstract Background The Pediatric onset multiple sclerosis (POMS) prevalence is increasing
worldwide accounting for around 3 to 10% of MS cases. The risk of POMS is supposed to …
worldwide accounting for around 3 to 10% of MS cases. The risk of POMS is supposed to …
Urine neopterin in childhood acute demyelinating diseases: Potential for differential diagnosis
Inflammatory demyelinating diseases of the central nervous system (CNS) in childhood
include clinically and radiologically defined diseases such as acute disseminated …
include clinically and radiologically defined diseases such as acute disseminated …
Re-examining the characteristics of pediatric multiple sclerosis in the era of antibody-associated demyelinating syndromes
Ü Yılmaz, K Gücüyener, M Yavuz, İ Öncel… - European Journal of …, 2022 - Elsevier
Background The discovery of anti-myelin oligodendrocyte glycoprotein (MOG)-IgG and anti-
aquaporin 4 (AQP4)-IgG and the observation on certain patients previously diagnosed with …
aquaporin 4 (AQP4)-IgG and the observation on certain patients previously diagnosed with …
Characteristics of pediatric multiple sclerosis: A tertiary referral center study
Objective The present study represents one of the largest series of pediatric multiple
sclerosis (PedMS) in Western Balkan region. This is the first study aimed to evaluate the …
sclerosis (PedMS) in Western Balkan region. This is the first study aimed to evaluate the …
Seasonal variability of serum 25-hydroxyvitamin D on multiple sclerosis onset
Vitamin D deficiency is associated with an increased risk of multiple sclerosis (MS).
However, its effect on the age of disease onset remains unclear. This study examines the …
However, its effect on the age of disease onset remains unclear. This study examines the …